HBI
62
4
DE
53
8
PG
51
3
LEG
27
-2
SWN
77
4
TAP
45
-6
LNC
52
2
AEE
61
3
CMS
67
3
LB
38
-7
D
60
5
RSG
59
2
TGNA
48
-2
GM
58
-2
SO
66
2
SBUX
41
-3
MAT
51
-3
KSS
39
6
PDCO
54
-4
MMM
52
2
HBI
62
4
DE
53
8
PG
51
3
LEG
27
-2
SWN
77
4
TAP
45
-6
LNC
52
2
AEE
61
3
CMS
67
3
LB
38
-7
D
60
5
RSG
59
2
TGNA
48
-2
GM
58
-2
SO
66
2
SBUX
41
-3
MAT
51
-3
KSS
39
6
PDCO
54
-4
MMM
52
2
Financhill
Back

Canadian Natural Resources Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
50

CNQ.TO
Canadian Natural Resources

Last Price:
45.25
Seasonality Move:
0.48%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
50
Canadian Natural Resources (CNQ.TO) is a Sell

Is Canadian Natural Resources a Buy, Sell or Hold?

  • The current Canadian Natural Resources [CNQ.TO] share price is $45.25. The Score for CNQ.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CNQ.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CNQ.TO Stock Price Chart

What is Canadian Natural Resources's stock price today?

  • The Canadian Natural Resources share price today is $45.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNQ.TO is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CNQ.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 43.92 Sell
Chaikin Money Flow: -8689300 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.54 - 49.24) Sell
Bollinger Bands (100): (46.51 - 51.21) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CNQ.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.5 Buy
20-day SMA: 46.32 Sell
50-day SMA: 47.59 Sell
200-day SMA: 47.69 Sell
8-day EMA: 45 Buy
20-day EMA: 45.87 Sell
50-day EMA: 47.21 Sell
200-day EMA: 47.25 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Canadian Natural Resources Earnings Growth & CNQ.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.17 per share, and an increase next year of $0.66 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Canadian Natural Resources Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):